Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

BACKGROUND: The unprecedented efficacy of chimeric antigen receptor T (CAR-T) cell immunotherapy of CD19(+) B-cell malignancies has opened a new and useful way for the treatment of malignant tumors. Nonetheless, there are still formidable challenges in the field of CAR-T cell therapy, such as the bi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Ying, Zhitao, He, Ting, Wang, Xiaopei, Zheng, Wen, Lin, Ningjing, Tu, Meifeng, Xie, Yan, Ping, Lingyan, Zhang, Chen, Liu, Weiping, Deng, Lijuan, Wu, Meng, Feng, Feier, Leng, Xin, Du, Tingting, Qi, Feifei, Hu, Xuelian, Ding, Yanping, Lu, Xin-an, Song, Yuqin, Zhu, Jun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2021
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7908740/
https://ncbi.nlm.nih.gov/pubmed/33632155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-07934-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller